Atherosclerosis is the leading cause of cardiovascular disease. The management of atherosclerosis reduces the risk of myocardial infarction and its related deaths. In this study, we developed an experimental confocal dual-pulse (20 Kv, 0.1 Hz and 8 Kv, 5 Hz) electrohydraulic shock wave generator, and investigated its effectiveness on advanced atherosclerotic plaque regression.

Confocal dual-pulse electrohydraulic shock wave therapy for advanced atherosclerosis regression accompaniedby atorvastatin-loaded microbubbles administration

2017

Abstract

Atherosclerosis is the leading cause of cardiovascular disease. The management of atherosclerosis reduces the risk of myocardial infarction and its related deaths. In this study, we developed an experimental confocal dual-pulse (20 Kv, 0.1 Hz and 8 Kv, 5 Hz) electrohydraulic shock wave generator, and investigated its effectiveness on advanced atherosclerotic plaque regression.
2017
FARMACOLOGIA TRASLAZIONALE - IFT
atherosclerosis
shock wave therapy
cardiovascular disease
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.14243/344482
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact